Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | CCR1 | P32246 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28517555 | 0.75 | KDM4E (0.54) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| Hydrochloric Acid SCHEMBL1071824 | 0.74 | MAPT (0.40) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| Hydrochloric Acid SCHEMBL1071469 | 0.72 | SMN1; SMN2 (0.43) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| Hydrochloric Acid SCHEMBL1070025 | 0.69 | LMNA (0.40) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| Hydrochloric Acid SCHEMBL1072267 | 0.69 | CCR1 (0.40) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| Hydrochloric Acid SCHEMBL819577 | 0.68 | KDM4E (0.41) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| Hydrochloric Acid SCHEMBL5009057 | 0.68 | P2RX7 (0.40) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| Hydrochloric Acid SCHEMBL3078672 | 0.66 | CCR1 (0.36) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| SCHEMBL27587384 | 0.66 | LMNA (0.39) | KDM4EMAPTLMNASMN1; SMN2TDP1 | |
| SCHEMBL6131342 | 0.66 | CCR1 (0.39) | KDM4EMAPTLMNASMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7795167-B2 | Cyclopentadienyl complexes of group 6 substituted by silyl halides | BASELL POLYOLEFINE GMBH (DE) | 2010-09-14 | — | — | US | disclosed |
| EP-1778400-B1 | CYCLOPENTADIENYL COMPLEXES OF GROUP 6 SUBSTITUTED BY SILYL HALIDES | BASELL POLYOLEFINE GMBH (DE) | 2009-05-06 | — | — | EP | disclosed |
| US-20080097053-A1 | Cyclopentadienyl Complexes Of Group 6 Substituted By Silyl Halides | BASELL POLYOLEFINE GMBH (DE) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080097053-A1 | Cyclopentadienyl Complexes Of Group 6 Substituted By Silyl Halides | INTS6, PORCN, ORC3 | CHRM1 4044/4885KDM4E 3083/4885MAPT 3503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.